(Q45057714)

9 December 2017

title

Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement (English)

1 reference

9 December 2017

0 references

2

1 reference

9 December 2017

6

1 reference

9 December 2017

7

1 reference

9 December 2017

Vicente Molina

1

0 references

Javier Pascau

object named as

Javier Pascau

5

0 references

author name string

Santiago Reig

3

1 reference

9 December 2017

Javier Sanz

4

1 reference

9 December 2017

Tomás Palomo

8

1 reference

9 December 2017

language of work or name

1 reference

10 September 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

178

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

17-26

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-004-1981-9

9 December 2017

exact match

0 references

cites work

Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat.

1 reference

12 December 2020

Neural correlates of formal thought disorder in schizophrenia: preliminary findings from a functional magnetic resonance imaging study.

1 reference

12 December 2020

Architecture and cortical connections of the prefrontal cortex in the rhesus monkey.

1 reference

12 December 2020

The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics.

1 reference

12 December 2020

Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia

1 reference

12 December 2020

Cerebral metabolism and risperidone treatment in schizophrenia

1 reference

12 December 2020

SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine.

1 reference

12 December 2020

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

1 reference

12 December 2020

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

1 reference

12 December 2020

Subnucleus-specific loss of neurons in medial thalamus of schizophrenics

1 reference

12 December 2020

Pathophysiology of 'positive' thought disorder in schizophrenia

1 reference

12 December 2020

Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET)

1 reference

12 December 2020

The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.

1 reference

12 December 2020

Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum

1 reference

12 December 2020

Magnetic Resonance Imaging of Mediodorsal, Pulvinar, and Centromedian Nuclei of the Thalamus in Patients With Schizophrenia

1 reference

12 December 2020

Cerebral metabolic patterns in chronic and recent-onset schizophrenia

1 reference

12 December 2020

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

1 reference

12 December 2020

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

12 December 2020

Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia

1 reference

12 December 2020

Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine

1 reference

12 December 2020

Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia

1 reference

12 December 2020

PET and the [15O]H2O technique, Part 2: Choosing a significance threshold

1 reference

12 December 2020

Brain region effects of clozapine on amino acid and monoamine transmission

1 reference

12 December 2020

Reduced regional [14C]2-deoxyglucose uptake in response to long-term clozapine administration in rats

1 reference

12 December 2020

In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

1 reference

12 December 2020

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

1 reference

12 December 2020

Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients

1 reference

12 December 2020

Combining spatial extent and peak intensity to test for activations in functional imaging.

1 reference

12 December 2020

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

12 December 2020

Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A 99mTc-HMPAO study.

1 reference

12 December 2020

Clozapine: new research on efficacy and mechanism of action

1 reference

12 December 2020

Thalamic connections of the insula in the rhesus monkey and comments on the paralimbic connectivity of the medial pulvinar nucleus.

1 reference

12 December 2020

D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine.

1 reference

12 December 2020

Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease

1 reference

12 December 2020

D2-dopamine receptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects

1 reference

12 December 2020

Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia.

1 reference

12 December 2020

Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.

1 reference

12 December 2020

PET and MRI of the thalamus in never-medicated patients with schizophrenia.

1 reference

12 December 2020

D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients

1 reference

12 December 2020

Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task

1 reference

12 December 2020

Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study.

1 reference

12 December 2020

Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics.

1 reference

12 December 2020

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

12 December 2020

The thalamus as a site of action of antipsychotic drugs

1 reference

12 December 2020

Functional effects of antipsychotic drugs: comparing clozapine with haloperidol

1 reference

12 December 2020

Influence of the normalization template on the outcome of statistical parametric mapping of PET scans.

1 reference

12 December 2020

Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol

1 reference

12 December 2020

Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex

1 reference

12 December 2020

Clozapine effects on glucose metabolic rate in striatum and frontal cortex

1 reference

12 December 2020

Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.

1 reference

12 December 2020

10.1007/S00213-004-1981-9

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

1026262181

0 references

1 reference